MedPath

"Resilient Caregivers" - A Resilience-based Intervention for Distressed Partner Cancer Caregivers

Not Applicable
Conditions
Distress, Emotional
Interventions
Other: Care as usual
Behavioral: "Resilient Caregivers"
Registration Number
NCT04610034
Lead Sponsor
Danish Cancer Society
Brief Summary

The objective of this study is to develop and test the effectiveness of a resilience-based intervention for distressed partner caregivers of cancer patients in reducing symptoms of anxiety, depression and distress, while improving quality of life and resilience (meta-reflective skill, values clarification and coping strategies).

Detailed Description

Informal caregivers of cancer patients often experience significant psychological distress, which may even exceed that of the patient's. Partners or spouses are typically the most important caregiver and emotional support person for the cancer patient, but there is a lack of psychological interventions that specifically target caregiving partners. "Resilient Caregivers" is a novel 7-session group-based program aimed specifically at improving the participant's ability to cope with the stresses of being a partner to a cancer patient. In this randomized trial, the investigators aim to assess the potential efficacy of this program in improving the caregiver's resilience and quality of life, as well as reducing symptoms of anxiety, depression and distress. Outcomes will be assessed at baseline and at 3, 6 and 12-months follow-up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Partner/Spouse to a patient diagnosed with Stage I-III cancer and receiving cancer treatment at Herlev Hospital
  • Patient performance status 1 or 2
  • Distress Thermometer score > 4
  • Able to speak and understand Danish
  • Has given written informed consent to participate in the study
Exclusion Criteria
  • Being a cancer patient
  • Has untreated psychopathology or physical impairment that may prevent attendance and participation in the study
  • Active substance abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupCare as usualCare as usual
"Resilient Caregivers""Resilient Caregivers"Intervention program
Primary Outcome Measures
NameTimeMethod
Change in symptoms of anxietyBaseline, 3 months, 6 months and 12 months follow-up

Measured by Generalized Anxiety Disorder-7 (GAD-7); range 0-21; higher scores = more symptoms

Secondary Outcome Measures
NameTimeMethod
Change in perceived stressBaseline, 3 months, 6 months and 12 months follow-up

Measured by Perceived Stress Scale (PSS-10); range 0-40; higher scores = higher perceived stress

Change in symptoms of depressionBaseline, 3 months, 6 months and 12 months follow-up

Measured by Patient Health Questionnaire-9 (PHQ-9); range 0-27; higher scores = more symptoms

Change in valued livingBaseline, 3 months, 6 months and 12 months follow-up

Measured by the "Obstruction subscale" from the Valuing Questionnaire (VQ); range 0-30; higher scores = more interference with living consistently with one's values

Change in resilienceBaseline, 3 months, 6 months and 12 months follow-up

Measured by Connor-Davidson Resilience Scale (CD-RISC-10); range 0-40; higher scores = greater resilience

Change in rumination/worry and copingBaseline, 3 months, 6 months and 12 months follow-up

Measured by Cognitive Attentional Syndrome Scale (CAS-1); range 0-100; higher scores = worse rumination/worry and coping

Change in psychological distressBaseline, 3 months, 6 months and 12 months follow-up

Measured by the Distress Thermometer; range 0-10; higher scores = higher distress

Change in sleep qualityBaseline, after completion of intervention (approximately 3 months from inclusion), 6 months and 12 months follow-up

Measured by the Pittsburg Sleep Quality Index (PSQI); range 0-21; higher scores = worse sleep quality

Change in quality of lifeBaseline, 3 months, 6 months and 12 months follow-up

Measured by World Health Organization-5 Well-being Index (WHO-5); range 0-25; higher scores = better quality of life

Trial Locations

Locations (1)

Herlev Hospital

🇩🇰

Herlev, Denmark

© Copyright 2025. All Rights Reserved by MedPath